Demographics and Clinical Characteristics of Patients With Opioid Use Disorder and Offered Medication-Assisted Treatment in the Emergency Department

被引:0
|
作者
Fu, Wayne [1 ,2 ]
Adzhiashvili, Victoria [3 ]
Majlesi, Nima [4 ]
机构
[1] Mercy Hosp, Emergency Med, Buffalo, NY 14220 USA
[2] Staten Isl Univ Hosp, Emergency Med, Staten Isl, NY 10305 USA
[3] Staten Isl Univ Hosp, Psychiat, Staten Isl, NY USA
[4] Staten Isl Univ Hosp, Med Toxicol, Staten Isl, NY USA
关键词
buprenorphine; substance abuse; drug addiction; medication for opioid use disorder; opioid use disorders; BUPRENORPHINE;
D O I
10.7759/cureus.41464
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective The opioid use disorder (OUD) epidemic is a persistent public health crisis in the United States. Medication -assisted treatment (MAT) with opioid agonists, including buprenorphine, is an effective treatment and is commonly initiated in the emergency department (ED). This study describes the demographics and clinical characteristics of OUD patients presenting to the ED and evaluated for MAT. Methodology A retrospective, single-center descriptive study of 129 adult patients presenting to the ED between July 2018 and July 2020 with OUD and evaluated for MAT. Results A total of 129 patients were assessed for MAT. About half (53%) received MAT; the remaining received only a referral (35%) or declined any intervention (12%). The median age was 36 years interquartile range (IQR, 28-46 years) and predominantly male (73%), single (65%), white (73%), unemployed (57%) with public insurance (55%), and without a primary care physician (58%). Majority of the patients presented with opioid withdrawal (62%) or intoxication (15%), while 23% presented with other complaints. About half of the patients (51%) were discharged with a naloxone kit. The majority of the patients were induced with buprenorphine with 4 mg or less (54%) and only 6% of patients received repeat dosing. Conclusions Male, white patients who are unmarried and unemployed, lack primary care follow-up, and rely on public insurance are more likely to be candidates for MAT. Providers should always maintain a high suspicion of opioid misuse and optimize treatment for those in withdrawal. Understanding these characteristics in conjunction with recent health policy changes will hopefully guide and encourage ED-initiated interventions in combating the opioid crisis.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions
    Chang, Derek C.
    Klimas, Jan
    Wood, Evan
    Fairbairn, Nadia
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2018, 44 (02): : 143 - 146
  • [22] SLEEP ARCHITECTURE IN INDIVIDUALS RECEIVING METHADONE FOR MEDICATION-ASSISTED TREATMENT OF OPIOID USE DISORDER
    Erwin, J. A.
    Wilson, M.
    Finlay, M.
    Hansen, D. A.
    Little-Gott, A.
    Reynolds, D.
    Quock, R. M.
    Layton, M. E.
    Van Dongen, H.
    SLEEP, 2020, 43 : A394 - A395
  • [23] A Multidisciplinary Resident-Led Training on Medication-Assisted Treatment for Opioid Use Disorder
    Trinh, Elyse
    Liu, Chi-Mei
    Murphy, Sara
    OBSTETRICS AND GYNECOLOGY, 2020, 135 : 66S - 67S
  • [24] EXPERIENCES OF MEDICATION-ASSISTED TREATMENT FOR OPIOID USE DISORDER AMONG WOMEN IN RECOVERY PROGRAMS
    Kedia, Satish K.
    Schmidt, Michael
    Dillon, Patrick J.
    Ahuja, Nikhil A.
    ANNALS OF BEHAVIORAL MEDICINE, 2021, 55 : S208 - S208
  • [25] Outcomes of adding cognitive behavioral therapy to medication-assisted treatment for opioid use disorder
    LeBlanc, Taylor
    Cromer, Pamela
    Gilliam, Stephen
    Johnson, Aaron
    Garvin, Jane
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2024, 36 (01) : 57 - 64
  • [26] Increasing Primary Care Utilization of Medication-Assisted Treatment (MAT) for Opioid Use Disorder
    Gardner-Buckshaw, Stacey L.
    Perzynski, Adam T.
    Spieth, Russell
    Khaira, Poojajeet
    Delos Reyes, Chris
    Novak, Laura
    Kropp, Denise
    Caron, Aleece
    Boltri, John M.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2023, 36 (02) : 251 - 266
  • [27] The impact of medication-assisted treatment for opioid use disorder on congestive heart failure outcomes
    Rasmussen, Peter
    Kuo, Yong-Fang
    Digbeu, Biai Dominique Elmir
    Harmouch, Wissam
    Mai, Steven
    Raji, Mukaila
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2024, 46
  • [28] Overcoming Barriers: Individual Experiences Obtaining Medication-Assisted Treatment for Opioid Use Disorder
    Scorsone, Krista L.
    Haozouss, Emily A.
    Hayes, Leslie
    Cox, Kim J.
    QUALITATIVE HEALTH RESEARCH, 2020, 30 (13) : 2103 - 2117
  • [29] The Impact of Medication-Assisted Treatment for Opioid Use Disorder on Congestive Heart Failure Outcomes
    Rasmussen, Peter
    Kuo, Yong-Fang
    Digbeu, Biai Dominique Elmir
    Harmouch, Wissam
    Mai, Steven
    Raji, Mukaila
    CIRCULATION, 2023, 148
  • [30] Treating Tobacco Use Disorder in Pregnant Women in Medication-Assisted Treatment for an Opioid Use Disorder: A Systematic Review
    Akerman, Sarah C.
    Brunette, Mary F.
    Green, Alan I.
    Goodman, Daisy J.
    Blunt, Heather B.
    Heil, Sarah H.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2015, 52 : 40 - 47